Pathology and Lab Medicine

Episodes 17-21 of 21

• 

  RestartResume

  Patient Selection for ADCs in First-Line DLBCL

  RestartResume

  Patient Selection for ADCs in First-Line DLBCL

  MinuteCE®

  Patient Selection for ADCs in First-Line DLBCL

  1.00 program credit

  • 

    

    John P. Leonard, MD

  • 

    

    Sarah Rutherford, MD

  1.00 program credit

• 

  RestartResume

  Application of Data from the ECHELON-1 Trial

  RestartResume

  Application of Data from the ECHELON-1 Trial

  MinuteCE®

  Application of Data from the ECHELON-1 Trial

  1.00 program credit

  • 

    

    Alison J. Moskowitz, MD

  • 

    

    Alex Herrera, MD

  1.00 program credit

• 

  RestartResume

  First-Line Treatment of Adults with Classical Hodgkin Lymphoma 

  RestartResume

  First-Line Treatment of Adults with Classical Hodgkin Lymphoma 

  MinuteCE®

  First-Line Treatment of Adults with Classical Hodgkin Lymphoma 

  1.00 program credit

  • 

    

    Alex Herrera, MD

  • 

    

    Alison J. Moskowitz, MD

  1.00 program credit

• 

  RestartResume

  Clinical Implications of Bispecific Antibodies and Antibody-Drug Conjugates in FL

  RestartResume

  Clinical Implications of Bispecific Antibodies and Antibody-Drug Conjugates in FL

  MinuteCE®

  Clinical Implications of Bispecific Antibodies and Antibody-Drug Conjugates in FL

  1.00 program credit

  • 

    

    Kami Maddocks, MD

  • 

    

    Matthew J. Matasar, MD

  1.00 program credit

• 

  RestartResume

  NCCN Guideline Updates in DLBCL

  RestartResume

  NCCN Guideline Updates in DLBCL

  MinuteCE®

  NCCN Guideline Updates in DLBCL

  1.00 program credit

  • 

    

    John P. Leonard, MD

  • 

    

    Sarah Rutherford, MD

  1.00 program credit

• Previous
• 1
• 2
• Next